fluoxetine has been researched along with Deficiency, Factor II in 1 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
Excerpt | Relevance | Reference |
---|---|---|
" Fluoxetine at the dosage studied does not predictably effect the hypoprothrombinemic response of warfarin." | 2.68 | Lack of effect of fluoxetine on the hypoprothrombinemic response of warfarin. ( Anderson, ML; Ford, MA; Jaskar, DW; Rindone, JP, 1997) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ford, MA | 1 |
Anderson, ML | 1 |
Rindone, JP | 1 |
Jaskar, DW | 1 |
1 trial available for fluoxetine and Deficiency, Factor II
Article | Year |
---|---|
Lack of effect of fluoxetine on the hypoprothrombinemic response of warfarin.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Anticoagulants; Drug Interactions; Fluoxetine; Humans | 1997 |